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SUMMARY. Objective. The aim is to investigate the influence of mother’s smoking and parity and fetal sex on AFP and
free -hCG in amniotic fluid and to examine the correlation between maternal serum and amniotic fluid marker concen-
trations. Methods. The study was performed on 233 second-trimester amniotic fluid samples. In 75 women, blood sample
was taken immediately before amniocentesis too. All pregnancies were singleton with normal fetal karyotype and out-
come. Concentrations of AFP and free -hCG were determined by fluoroimmunoassay and converted to MoM, according
to medians for unaffected pregnancies of the corresponding gestational age. Results. In smoking women, amniotic fluid
free -hCG was significantly lower than in non-smoking ones (p=0.033), though AFP was not significantly different in
regard to smoking habits (p=0.113). Significantly higher amniotic fluid free -hCG (p<0.001) and lower AFP (p=0.015)
were found in female, in comparison to fetal male gender. No significant change according to parity, neither for free
-hCG, nor for AFP was observed (p=0.094 and p=0.376, respectively). Significant correlation of AFP to free -hCG was
found between serum and amniotic fluid samples (r=0.61, p<0.001 and r=0.35, p<0.002, respectively). Conclusions. Our
results confirmed the influence of fetal sex on amniotic fluid AFP and free -hCG and negative influence of smoking on
free -hCG as well as on maternal serum AFP and free -hCG concentrations. More data should be available to determine
the impact of parity on examined amniotic fluid markers.
Izvorni rad
Klju~ne rije~i: plodova voda, alfa-fetoprotein, slobodni -hCG, spol fetusa, paritet, pu{enje
SA@ETAK. Cilj istra`ivanja. (1) Ispitati utjecaj pu{enja i rodnosti (pariteta) majke i spola fetusa na razinu alfa-fetoprotei-
na (AFP) i slobodne -podjedinice humanog korionskog gonadotropina (slobodni -hCG) u plodovoj vodi urednih trud-
no}a. (2) Ispitati korelacije izme|u serumskih vrijednosti AFP i slobodnog -hCG i vrijednosti spomenutih biljega u plo-
dovoj vodi. Ispitanice i metode. Ispitivanje je provedeno na 233 uzorka plodove vode koji su dobiveni amniocentezom u
drugom tromjese~ju trudno}e. U 75 slu~ajeva uzet je i uzorak krvi neposredno prije amniocenteze. Sve su trudno}e bile
jednoplodne, urednog tijeka i ishoda, a kariotip ploda bio je uredan. Koncentracije AFP i slobodnog -hCG odre|ivane su
fluoroimunometrijskom metodom i izra`ene u multiples of median (MoM) za odgovaraju}i tjedan trudno}e. Rezultati. U
plodovoj vodi trudnica pu{a~ica utvr|ena je statisti~ki zna~ajno ni`a razina slobodnog -hCG nego u nepu{a~ica
(p=0,033). Utjecaj pu{enja na razinu AFP u plodovoj vodi nije utvr|en (p=0,113). Nasuprot tomu, spol fetusa je zna~ajno
utjecao na razinu slobodnog -hCG i AFP u plodovoj vodi: razina slobodnog -hCG je bila statisti~ki zna~ajno vi{a, a
AFP zna~ajno ni`a ako je fetus bio `enskog spola (p<0,001 za slobodni -hCG; p=0,015 za AFP). Vrijednosti istra`ivanih
biljega u plodovoj vodi nisu se mijenjale u odnosu na paritet (p>0,05 za oba biljega). Statisti~ki zna~ajna korelacija
utvr|ena je za koncentracije AFP (r=0,61; p<0,001) i slobodnog -hCG (r=0,35; p<0,002) izme|u seruma i plodove
vode. Zaklju~ak. Rezultati ovog istra`ivanja potvr|uju utjecaj spola fetusa na vrijednosti slobodnog -hCG i AFP u plo-
dovoj vodi kao i negativan utjecaj pu{enja na razinu slobodnog -hCG. Promjene su istovjetne onima u serumu. Utjecaj
pariteta na ispitivane biljege u plodovoj vodi nije potvr|en, mogu}e zbog nedovoljnog broja uzoraka.
Introduction
Despite the great interest of numerous authors in
co-variables influencing serum biochemical markers for
prenatal screening of Down syndrome (DS) and neural
tube defects (NTD), there are still insufficient data con-
cerning its distribution in amniotic fluid. Some reports
tried to clarify if the changes of second-trimester pattern
of human chorionic gonadotropin (hCG) or its free sub-
———————
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units (free -hCG, free -hCG) as well as alpha-feto-
protein (AFP), mirrored on its levels in amniotic fluid.
1–3
The aim of the present study is to investigate possible
co-influence of smoking habits, parity and fetal sex on
AFP and free -hCG levels in amniotic fluid, as has
been earlier well documented for maternal serum.
4,5
Par-
ticular interest has been payed to find out if there is a
correlation of AFP and free -hCG levels between ma-
ternal serum and amniotic fluid in second-trimester un-
affected pregnancies.
Materials and Methods
A total of 233 samples of amniotic fluid, from preg-
nant women who underwent amniocentesis between 15
and 20 weeks’ gestation, were collected through the pe-
riod from April 2004 to February 2005. In 68% of cases
(n=158) the procedure was undertaken on the basis of
advanced maternal age, in 18% (n=42) on the basis of el-
evated risk in biochemical and/or ultrasonographic scre-
ening, and in 14% of women (n=33) because of the risks
from genetic or family disease history. Out of total, 75 of
studied women (32%) gave the informed consent for
taking blood sample, immediately before amniocente-
sis. All were singleton pregnancies, none of them was
conceived with methods of assisted reproduction and
there were no cases of insulin-dependent diabetes mel-
litus. The necessary patient’s data (maternal age and
weight, smoking habits and previous gravidity/parity)
were taken at the time of amniocentesis in a standard
manner, exactly as for biochemical screening. All preg-
nant women were white and of the same ethnic origin.
Gestational age was confirmed or established by ultra-
sonographic fetal biometry prior to the invasive proce-
dure. For this study, we selected only pregnancies with
normal fetal karyotype and those in which progress and
normal outcome was confirmed from obstetric and de-
livery room databases.
Amniotic fluid samples were centrifuged at 2000 rpm
for 10 min; amniocytes were then cultured for karyo-
typing. The supernatant was frozen at –20°C till analy-
sis, together with the corresponding serum sample. Bio-
chemical markers, alpha-fetoprotein and free -hCG,
were determined by fluorometric immunoassay DEL-
FIA (Perkin Elmer Life and analytical sciences, Wallac
Oy, Turku, Finland). Samples of amniotic fluid for mea-
suring AFP and free -hCG concentrations were diluted,
using zero-standard point, up to 1:100 and 1:5, respec-
tively. Concentrations of each marker were expressed in
multiples of the median (MoM) for unaffected pregnan-
cies of the corresponding gestational age. Medians of
serum markers were derived from a routine serum-scre-
ening program and were adjusted for maternal weight.
Regressed medians for gestation between 15
th
and 21
st
weeks were used for calculation of MoM values of
amniotic fluid markers.
Statistical analysis utilized descriptive statistics for
population parameters, 
2
-test for testing proportions
and one-way ANOVA for estimating differences between
continuos variables. The MoMs of MSAFP and free
-hCG were transformed in corresponding log
10
MoMs
in order to obtain a normally distributed set of values,
which allowed the application of parametric statistical
tests. Kolmogorov-Smirnov tests of goodness-to-fit to a
Gaussian distribution were demonstrated for both mark-
ers (p>0,20). Statistical significance was determined at
p level of 0.05. Pearsons’ coefficient was used for esti-
mating correlation of markers between serum and am-
niotic fluid.
Results
The mean maternal age of studied pregnant women
(n=233) was 33.8±5.5 (mean ± SD) and the gestational
age was 16.5±5.5. Table 1 shows the characteristics of
the study population, according to smoking status, par-
ity and fetal sex. We found significantly lower MoM
values of free -hCG in amniotic fluid (AF free -hCG
MoM) of smoking pregnant women, compared to non-
smoking ones (p=0.033) (Figure 1). In distinction to
that, amniotic fluid AFP MoM (AF AFP MoM) values
between smokers and non-smokers were not signifi-
cantly different (p=0.113) (Figure 1).
There were no significant differences in proportions
of women with female and male fetuses, neither in rela-
Table 1. Characteristics of the study population according to smoking status, parity and fetal gender
Tablica 1. Karakteristike istra`ivane populacije u odnosu na pu{a~ki status, paritet i spol fetusa
No. of cases – Broj trudno}a Free -hCG MoM AFP MoM
n (%) Median Mean log
10
±SD Median Mean log
10
±SD
Non-smokers – Nepu{a~ice 195 (83.7) 1.03 –0.0242±0.2203 0.89 –0.0257±0.1932
Smokers – Pu{a~ice 38 (16.3) 0.76 –0.1102±0.2518 1.01 0.0283±0.1809
Previous births – Raniji porodi
0 78 (33.5) 1.06 –0.0054±0.2448 0.95 0.0000±0.2166
1 108 (46.3) 1.02 –0.0328±0.2043 0.92 –0.0082±0.1890
2 37 (15.9) 0.79 –0.0997±0.2516 0.86 –0.0608±0.1408
3 10 (4.3) 0.67 –0.1261±0.1915 0.85 –0.0797±0.1672
Fetal gender – Spol fetusa
female – `enski 120 (51.5) 1.09 0.0260±0.2075 0.89 –0.0465±0.1856
male – mu{ki 113 (48.5) 0.79 –0.1064±0.2286 0.96 0.0145±0.1943
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tion to the number of previous births between non-
smokers and smokers (p>0.05). We revealed statisti-
cally significant difference between MoMs of both, AF
free -hCG and AF AFP in relation to fetal sex (p<0.001
and p=0.015, respectively) (Figure 2). AF free -hCG
MoMs were significantly higher in cases of pregnancies
with female than in those with male fetuses. On the other
hand, AF AFP MoM values in female pregnancies were
significantly lower than in male pregnancies. No signifi-
cant differences in proportions of smokers and non-
smokers and in proportions of women according to par-
ity, between male and female pregnancies, were found
(p>0.05). We found no significant changes with regard
to parity, neither of AF free -hCG MoM, nor of AF
AFP MoM values (p=0.094 and p=0.376, respectively).
In 75 paired samples the correlation between serum
and amniotic fluid AFP and free -hCG MoM values
was analyzed. Statistically significant positive correla-
tion was found for log
10
free -hCG MoM values (r=
0.61, p<0.001). On the other side, positive, although
weak correlation was found for log
10
AFP MoM values
(r=0.35, p=0.002). Moreover, significant positive corre-
lation between serum and amniotic fluid free -hCG
MoM values was determined in smokers and non-smok-
ers (r=0.71, p=0.003 and r=0.58, p<0.0001, respective-
ly). We also found significant correlation of free -hCG
MoM values between serum and amniotic fluid, in both
female and male pregnancies (r=0.54, p=0.0003 and
r=0.74, p<0.0001, respectively).
Discussion
The aim of the present study was to investigate the in-
fluence of cigarette consumption, parity and fetal sex on
amniotic fluid concentrations of free -hCG and AFP,
as well as to investigate the correlation of biochemical
markers between matched serum and amniotic fluid. As
we mentioned in our previous report
6
, women submitted
to the program of prenatal care in Croatia constituted an
almost homogenous population, regarding race and eth-
nic origin, so they represented a suitable model for re-
search of the influence of co-factors on biochemical
markers.
It has been known that AFP concentrations in the
amniotic fluid of normal pregnancies are 10
2
–10
3
times
higher than in maternal serum at the same gestation and
that levels decrease with increasing gestational age,
while concentrations in maternal blood increase with
gestational age.
2
On the other side, the concentrations of
free -hCG are 5–10 times higher in amniotic fluid than
those in maternal serum and decrease with gestational
age in both fluid compartments.
1,2
Our results confirmed good and significant positive
correlation for free -hCG MoM values between mater-
nal serum and amniotic fluid during second trimester of
pregnancy. Previously, similar observations were re-
ported on total hCG in the second and third trimester.
3,7
On the other hand, we found weak, although significant
correlation for AFP MoMs between maternal circula-
tion and amniotic fluid compartment. Still, with sample
size presented in this study, we detected the correlation
significant, with power level of 80% (=0.05). Some
earlier studies have shown no significant correlation be-
tween AFP concentrations in maternal serum and am-
niotic fluid.
8,9
The authors supposed that simple diffu-
sion might not be the only mechanism for the transfer of
AFP from amniotic fluid to maternal serum. As had
been postulated, the main contribution of AFP in am-
niotic fluid, after 14 weeks' gestation, is reached via fe-
tal kidneys and urine. In normal pregnancies, two mech-
anisms are responsible for fetal-to-maternal transfer:
transplacental, driven by hydrostatic gradient across the
placental villous surface and other, with the passage
through the basal plate, in which AFP gains entrance to
maternal vessels that traverse decidua basalis and basal
Figure 1. Mean log
10
MoMs of amniotic fluid free -hCG and AFP ac-
cording to smoking habits
Slika 1. Srednja vrijednost log
10
MoM slobodnog -hCG i AFP u plodovoj
vodi ovisno o pu{a~kom statusu trudnice
Figure 2. Mean log
10
MoMs of amniotic fluid free -hCG and AFP ac-
cording to fetal gender
Slika 2. Srednja vrijednost log
10
MoM slobodnog -hCG i AFP u plodovoj
vodi ovisno o spolu fetusa
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plate.
10,11
It has also been elucidated that placental tissues
produce hCG and its subunits throughout pregnancy.
Namely, syncytiotrophoblast, which is the major com-
ponent of chorionic villi, secretes hCG and its subunits
directly into maternal blood. On the other side, amniotic
fluid that resides the compartments surrounding the tro-
phoblastic tissue also contains a certain amount of hCG
and, even significant amount of its - and -subunit.
1
Our results demonstrate good and significant correlation
for free -hCG MoM values between maternal circula-
tion and amniotic fluid compartment, no matter of fetal
sex, and also independently of maternal smoking habits.
The present study shows significantly depressed free
-hCG MoM values in amniotic fluid of smoking preg-
nant women in relation to non-smoking subjects. We re-
ported the same effect on second-trimester maternal sera
in our earlier investigation
4
, which was a continuation of
some previous studies concerning negative influence of
smoking on serum concentration of total hCG
12,13
and
free -hCG.
14,15
On the other hand, the effect of smoking
on maternal serum AFP concentrations has been less ev-
ident.
14,15,16
Our earlier results obtained on maternal
sera,
4
as well as results on amniotic fluid presented here,
are on the same trail. Slightly increased AFP MoM val-
ues in amniotic fluid of our smoking women, compared
to non-smokers, are not significantly different. Ver-
spyck et al.
17
reported similar observation.
Although the impact of fetal sex on maternal serum
concentrations of AFP and free -hCG has been well
documented in literature,
5,18–22
the attitude towards the
influence on biochemical markers in amniotic fluid is
still erratic. In the present study, significantly higher
amniotic fluid free -hCG MoM and lower AFP MoM
values were found in pregnancies with female in com-
parison to those with male gender. Spencer et al.
2
found
consistently higher free -hCG MoM values in all gesta-
tional weeks, in amniotic fluid of unaffected pregnan-
cies with female fetuses, but they could not prove any
significant differences in AF AFP MoM values in rela-
tion to fetal sex. Drugan et al.
23
found similar AF AFP
MoM values in singleton pregnancies regardless to male
or female fetus. Some other studies confirmed that
amniotic fluid of male fetuses more often contained ele-
vated AFP MoM values, compared to those in fema-
les.
17,24
In spite of uneven conclusions in the literature,
our results are supporting the hypothesis that gender
specific regulatory mechanisms are responsible for dif-
ferent production, secretion and feto-maternal transfer
of placental and fetal proteins, which is evident in both
fluid compartments.
In our previous investigation on maternal serum mar-
kers we were unable to document a clear trend of chan-
ges for MS AFP MoM values, in relation to parity.
4
This
was also in agreement with the results of Spencer
25
and
Wald.
26
Recently, Lei et al.
27
in an extensive population
study, described the increased occurrence of absolute
and relative proportion of low maternal serum AFP lev-
els in line with the increased parity. In the present study,
the results have not shown any coherent association be-
tween MoM values of AF AFP and the number of previ-
ous births. Also Verspyck et al.
17
did not observe signifi-
cant difference in mean AF AFP MoM, in relation to
parity. In our previous report, we confirmed signifi-
cantly higher free -hCG MoM in sera of primigravidas,
while increasing parity negatively affected the average
free -hCG MoM values.
4
On the other side, free -hCG
MoM values in amniotic fluid samples presented in this
study have shown decreasing trend with parity, although
the significance of the direction hasn’t been proved.
These data cannot be compared with the literature, for
the lack of reports on free -hCG in amniotic fluid in re-
lation to previous gravidity and parity.
In conclusion, our results confirm the influence of fe-
tal sex on amniotic fluid AFP and free -hCG MoM val-
ues and, also, the influence of cigarette smoking on
amniotic fluid free -hCG MoMs. No significant differ-
ences, for neither of studied amniotic fluid biochemical
markers, according to parity were observed. Significant,
good positive correlation was demonstrated for free
-hCG MoM values between maternal serum and am-
niotic fluid. Regarding the lack of agreement among
these and previously reported results, further investiga-
tion will be required to determine the possible influence
of co-variables on amniotic fluid biochemical markers.
References
1. Ozturk M, Brown N, Milunsky A, Wands J. Physiologi-
cal studies on human chorionic gonadotropin and free subunits in
the amniotic fluid compartment compared to those in maternal
serum. J Clin Endocrinol Metab 1998;67:1117–21.
2. Spencer K, Muller F, Aitken DA. Biochemical markers
of trisomy 21 in amniotic fluid. Prenat Diagn 1997;17:31–7.
3. Steier JA, Myking LO, Bergsjø BP. Correlation between
fetal sex and human chorionic gonadotropin in peripheral mater-
nal blood and amniotic fluid in second and third trimester normal
pregnancies. Acta Obstet Gynecol Scand 1999;78:367–71.
4. Ti{lari} D, Brajenovi}-Mili} B, Risti} S, Latin V, @u-
vi}-Butorac M, Ba~i} J, Petek M, Kapovi} M. The influence of
smoking and parity on serum markers for Down’s syndrome
screening. Fetal Diagn Ther 2003;17:17–21.
5. Spencer K. The influence of fetal sex in screening for
Down syndrome in the second trimester using AFP and free
ß-hCG. Prenat Diagn 2000;20:648–51.
6. Brajenovi}-Mili} B, Ti{lari} D, @uvi}-Butorac M, Ba~i}
J, Petrovi} O, Risti} S, Mimica M, Kapovi} M. Elevated second
trimester free -hCG as an isolated finding and pregnancy out-
come. Fetal Diagn Ther 2004;19:483–7.
7. Chen RJ, Huang SC, Chow SN, Hsieh CY. Human chori-
onic gonadotropin pattern in maternal circulation, amniotic fluid
and fetal circulation in later pregnancy. J Reprod Med 1993;
38:151–4.
8. Barford DA, Dickerman LH, Johnson WE. Alpha-feto-
protein: relationship between maternal serum and amniotic fluid
levels. Am J Obstet Gynecol 1985;151:1038–41.
18
Gynaecol Perinatol 2007;16(1):14–18 Brajenovi}-Mili} B et al. The influence of fetal sex and mother’s smoking and parity on AFP…
9. Hsu JJ, Hseih TT, Chiu Th, Liou JD, Soong YK. Al-
pha-fetoprotein levels of paired samples between the amniotic
fluid and maternal serum from 16 to 18 weeks’ gestation in Chi-
nese women. J Formos Med Assoc 1994;93:374–8.
10. Van Lith MM, Beekhuis JR, Van Loon AJ, Mantingh
A, De Wolf BTHM, Breed ASPM. Alpha-fetoprotein in fetal se-
rum, amniotic fluid and maternal serum. Prenat Diagn 1991;
11:625–8.
11. Mizejewski GJ. Alpha-fetoprotein structure and function:
Minireview. Exp Biol Med 2001;226:377–408.
12. Bernstein L, Pike MC, Lobo RA, Depue RH, Ross RK,
Henderson BE. Cigarette smoking in pregnancy results in mar-
ked decrease in maternal hCG and oestradiol levels. Br J Obstet
Gynecol 1989;96:92–6.
13. Cucle HS, Wald NJ, Densem JW, Royston. The effect
of smoking in pregnancy on maternal serum alpha-fetoprotein,
unconjugated estriol, human chorionic gonadotropin, progester-
one and dehydro-epiandrosterone sulphate levels. Br J Obstet
Gynaecol 1990;97:272–6.
14. Spencer K. The influence of smoking on maternal se-
rum AFP and free beta hCG levels and the impact on screening
for Down syndrome. Prenat Diagn 1998;18:225–34.
15. Perona M, Mancini G, Dall'Amico D, Guaraldo V, Car-
bonara A. Influence of smoking habits on Down's syndrome risk
evaluation at mid-trimester through biochemical screening. Int J
Clin Lab Res 1998;28:179–82.
16. Haddow JE, Palomaki G, Kloza EM, Knight GJ. Does
smoking influence serum -fetoprotein levels in mid-trimester
pregnancies? Br J Obstet Gynaecol 1984;91:1188–97.
17. Verspyck E, Degré S, Hellot MF et al. Amniotic fluid al-
pha-fetoprotein is not a useful biological marker of pregnancy
outcome. Prenat Diagn 1999;19:1031–4.
18. Bazzett BL, Yaron Y, O’Brien EJ et al. Fetal gender im-
pact on multiple-marker screening results. Am J Med Genet
1998;76:369–71.
19. De Graaf MI, Cucle HS, Pajkrt E, Leschot JN, Bleker
PO, van Lith JMM. Co-variables in first-trimester maternal sc-
reening. Prenat Diagn 2000;20:186–9.
20. Spencer K, Ong CY, Liao AW, Papademetriou D, Nicolai-
des KH. The influence of fetal sex in screening of trisomy 21 by
fetal nuchal translucency, maternal serum free -hCG and PAPP-A
at 10–14 weeks of gestation. Prenat Diagn 2000;20:673–5.
21. Yaron Y, Lehavi O, Orr-Urtreger A, Gull I, Lessing BJ,
Amit A, Ben-Yosef D. Maternal serum hCG is higher in the pres-
ence of a female fetus as early as week 3 post-fertilization. Hum
Reprod 2002;2:485–9.
22. Mueller VM, Huang T, Summers AM, Winsor SHM.
The effect of fetal gender on the false-positive rate of Down syn-
drome by maternal serum screening. Prenat Diagn 2005;25:
1258–61.
23. Drugan A, Yaron Y, Murphy J, Ebrahim SAD, Kramer
RL, Johnson MP, Evans MI. No effect of fetal sex on amniotic
fluid alpha-fetoprotein. Fetal Diagn Ther 1997;12:301–3.
24. Knippel JA. Role of fetal sex in amniotic fluid alpha-
fetoprotein screening. Prenat Diagn 2002;22:941–5.
25. Spencer K. The influence of gravidity on Down’s syndro-
me screening with free beta hCG. Prenat Diagn 1995;15:87–9.
26. Wald NJ, Watt HC. Serum markers for Down's syndro-
me in relation to number of previous births and maternal age.
Prenat Diagn 1996;16:699–703.
27. Lei U, Wohlfahrt J, Christens P, Westergaard T, Lambe
M, Norgaard-Pedersen B. Reproductive factors and extreme lev-
els of maternal serum alpha-fetoprotein: A population based
study. Acta Obstet Gynecol Scand 2004;83:1147–51.
Paper received: 7. 10. 2006; accepted: 30. 11. 2006. Address for correspondence: Prof. dr. sc. Bojana Brajeno-
vi}-Mili}, Department of Biology and Medical Genetics, School
of Medicine, University of Rijeka, Bra}e Branchetta 22, 51 000
Rijeka, Croatia, E-mail: bojanaºmedri.hr
VIJESTI
NEWS

8
th
WORLD CONGRESS OF PERINATAL MEDICINE
Firenze, Italy, 9–13 September 2007
Opening lectures: Genetics in the changing world; Environment and influence in the reproduction and offspring;
Perinatal ethics: is it a fashion?; Pharmaceutics and perinatal medicine: where is the challenge?
Plenary sessions: Perinatal genetics; Perinatal origin of adult diseases; Preterm labour and prematurity challenges;
Drug monitoring and clinical toxicology in perinatal medicine.
Additional 43 concurrent and parallel sessions!
Free communications
Registration fees. Before December 2006: delegates € 400, residents and midwifes € 200, accompanying persons
€ 100; Before August 2007: €-s 500, 250 and 110; On-site: €-s 600, 300, 120.
Information. Organizing Secretariat: MCA Events srl, Via G. Pelizza da Volpedo 4, 20149 Milano, Italia.
Tel. +39 023 4934404; Fax. +39 023 4934397; E-mail: infoºwcpm8.org
